Karolinska Development AB ser. B (KDEV) - Total Liabilities
Based on the latest financial reports, Karolinska Development AB ser. B (KDEV) has total liabilities worth Skr6.55 Million SEK (≈ $704.78K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Karolinska Development AB ser. B - Total Liabilities Trend (2007–2025)
This chart illustrates how Karolinska Development AB ser. B's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Karolinska Development AB ser. B's working capital to evaluate short-term liquidity relative to the company's equity base.
Karolinska Development AB ser. B Competitors by Total Liabilities
The table below lists competitors of Karolinska Development AB ser. B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
HyosungONBCo.Ltd
KQ:097870
|
Korea | ₩10.37 Billion |
|
Camellia Metal Co Ltd
TWO:2064
|
Taiwan | NT$1.52 Billion |
|
Enra Group Bhd
KLSE:8613
|
Malaysia | RM123.02 Million |
|
Touchstone Exploration Inc
TO:TXP
|
Canada | CA$164.80 Million |
|
AJ Bell plc
LSE:AJB
|
UK | GBX85.63 Million |
|
IT Link
PA:ALITL
|
France | €31.36 Million |
|
K2A Knaust & Andersson Fastigheter AB (publ)
ST:K2A-B
|
Sweden | Skr5.32 Billion |
|
Chin Yang Chem
KO:051630
|
Korea | ₩42.53 Billion |
Liability Composition Analysis (2007–2025)
This chart breaks down Karolinska Development AB ser. B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see KDEV stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 128.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Karolinska Development AB ser. B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Karolinska Development AB ser. B (2007–2025)
The table below shows the annual total liabilities of Karolinska Development AB ser. B from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr8.34 Million ≈ $897.73K |
-37.07% |
| 2024-12-31 | Skr13.26 Million ≈ $1.43 Million |
+14.59% |
| 2023-12-31 | Skr11.57 Million ≈ $1.25 Million |
+13.33% |
| 2022-12-31 | Skr10.21 Million ≈ $1.10 Million |
-92.61% |
| 2021-12-31 | Skr138.19 Million ≈ $14.87 Million |
+53.86% |
| 2020-12-31 | Skr89.82 Million ≈ $9.67 Million |
-43.50% |
| 2019-12-31 | Skr158.97 Million ≈ $17.11 Million |
-68.10% |
| 2018-12-31 | Skr498.38 Million ≈ $53.63 Million |
+25.81% |
| 2017-12-31 | Skr396.14 Million ≈ $42.63 Million |
-3.03% |
| 2016-12-31 | Skr408.50 Million ≈ $43.96 Million |
+11.44% |
| 2015-12-31 | Skr366.58 Million ≈ $39.45 Million |
+465.50% |
| 2014-12-31 | Skr64.82 Million ≈ $6.98 Million |
+155.46% |
| 2013-12-31 | Skr25.38 Million ≈ $2.73 Million |
-86.70% |
| 2012-12-31 | Skr190.81 Million ≈ $20.53 Million |
+10.98% |
| 2011-12-31 | Skr171.93 Million ≈ $18.50 Million |
+204.56% |
| 2010-12-31 | Skr56.45 Million ≈ $6.08 Million |
+40.33% |
| 2009-12-31 | Skr40.23 Million ≈ $4.33 Million |
+204.40% |
| 2008-12-31 | Skr13.22 Million ≈ $1.42 Million |
-79.92% |
| 2007-12-31 | Skr65.83 Million ≈ $7.08 Million |
-- |
About Karolinska Development AB ser. B
KDventures AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in th… Read more